CIDRAP

Once-weekly HIV therapy may offer alternative to daily pills

A once-weekly oral HIV treatment maintained viral suppression as effectively as a standard once-daily regimen in a phase 3 ...
HealthDay on MSN

Once-weekly oral islatravir-lenacapavir noninferior to daily B/F/TAF in HIV

For adults with virologically suppressed HIV-1, once-weekly oral islatravir-lenacapavir (ISL/LEN) is noninferior to ...

Doravirine works as well as dolutegravir to suppress HIV viral load, study finds

If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been ...

HIV: Once-Weekly Pill As Effective As Daily Treatment, Global Study Finds

A once-weekly HIV pill combining the antiretroviral drugs islatravir and lenacapavir is as effective as a widely used once-daily regimen, according to an international study. More than 93% of ...
clinicaladvisor.com

Monitoring HIV Viral Load Critical for Preventing Low-Level Viremia, Virologic Failure

A CD4+ count below 200 cells/μL, advanced age at antiretroviral therapy initiation, and protease inhibitor use were associated with low-level viremia and increased risk for virologic failure among ...

ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced ...
Medscape

Baseline Viral Load Shapes Immune Response in Women With HIV

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...
MedPage Today

Viral Load: HIV's Most Important Disease Marker

Reviewed by Carrie D. Johnston, MD, MS, Assistant Professor in the Division of Infectious Diseases at Weill Cornell Medical College in New York City. "Medical Journeys" is a set of clinical resources ...